NCT07526285
Personalized Repetitive Transcranial Magnetic Stimulation (PrTMS) for Treatment of Post-Traumatic Stress Disorder (PTSD)
At risk: Primary completion moved 10 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Jul 31, 2028 to May 31, 2029 Show 5 more changesShow less
- Start date: Aug 1, 2026 to Jun 1, 2027
- Eligibility criteria expanded, about 17 words
- Study completion pushed from Jan 31, 2029 to Dec 31, 2029
- Secondary endpoints: details revised at 8 of 25 entries
- Publications: details revised at 3 of 3 entries
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (25)
Show 20 moreShow less
Arms and interventions
Participants receive personalized, EEG-guided repetitive transcranial magnetic stimulation (PrTMS) administered 5 days per week for 6 weeks, with stimulation parameters individualized and adjusted over time based on serial sEEG and neurocognitive assessments.
Participants receive sham repetitive transcranial magnetic stimulation (rTMS) administered 5 days per week for 6 weeks using a sham coil that mimics the sound and sensation of active treatment without delivering a therapeutic magnetic field.
Devices: Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation Sham
Sites
1 site in 1 country
- Home BaseCharlestown, Massachusetts, United States